Education; replace term auto-injectable epinephrine with epinephrine and consolidate provisions relating to epinephrine and schools
HB1056 updates Georgia law governing epinephrine use in schools and related health statutes by replacing the narrower term “auto-injectable epinephrine” with the broader term “epinephrine” throughout the affected code sections. The bill consolidates and rewrites the school-health provisions in Title 20 to address student possession, self-administration, storage, and emergency use of epinephrine, while also making conforming changes in the pharmacy and public health statutes.
Under the bill, local boards of education and other public school governing bodies must adopt policies allowing students to carry and self-administer prescription epinephrine when supported by annual written statements from a licensed practitioner and a parent or guardian. Schools may also store prescription epinephrine onsite for students who cannot self-administer, and they may stock epinephrine for emergency use under a prescription issued pursuant to state law. The bill also requires training or information for school employees on recognizing anaphylaxis and administering epinephrine, and it authorizes designated employees to provide or administer epinephrine in good faith during an anaphylactic reaction, even if the student does not have a prescription.
The bill further provides civil liability protections for schools, school employees, agents, and prescribing licensed practitioners when they act in good faith under the statute, while preserving liability for willful or wanton misconduct. It also authorizes schools to obtain epinephrine through manufacturers or third-party suppliers, and directs the State Board of Education, in consultation with the Department of Public Health, to adopt implementing regulations by July 1, 2026. Related amendments update pharmacist authority to dispense epinephrine for schools and authorized entities and revise the definition of epinephrine in the public health code.
The overall sentiment reflected by the bill text is strongly supportive of expanding and clarifying school access to epinephrine for allergic emergencies. No committee transcripts or recorded votes were provided, so there is no documented opposition or debate in the available materials. The structure of the bill suggests a policy goal of improving emergency preparedness in schools while reducing legal uncertainty for school personnel and medical prescribers.
Any likely points of contention would center on school liability, employee discretion in emergency administration, and the balance between student access and misuse prevention. The bill directly addresses those concerns by requiring policies to protect against misuse and abuse, mandating parental and practitioner documentation, and granting immunity for good-faith actions. It also broadens the law from a device-specific framework to a more general epinephrine framework, which may be viewed as a modernization but could require implementation adjustments by schools and health providers.
HB1056 amends Georgia’s education, pharmacy, and public health statutes to modernize and broaden the legal framework for epinephrine in schools and other authorized settings. It repeals and replaces the existing school epinephrine provisions in Title 20, updates pharmacist-prescribing and dispensing authority in Title 26, and revises the authorized-entities law in Title 31 to use the term “epinephrine” rather than “auto-injectable epinephrine.” The bill expands and clarifies who may prescribe, store, dispense, carry, and administer epinephrine, and it adds implementation authority for the State Board of Education and Department of Public Health.
The available materials indicate a generally favorable, public-safety-oriented bill with no recorded committee debate or vote history in the provided context. The measure appears designed to improve emergency response to anaphylaxis in schools and to reduce confusion by standardizing terminology and procedures. Because no opposition is documented, the sentiment can be characterized as supportive and largely noncontroversial in the available record.
No specific contention is documented in the provided transcripts or votes. Based on the bill text, the most likely areas of concern are the scope of school employee authority to administer epinephrine, the liability protections for schools and practitioners, and the requirement that schools adopt policies and training to prevent misuse while ensuring rapid emergency response. Another possible issue is the shift from “auto-injectable epinephrine” to the broader term “epinephrine,” which may require administrative and regulatory updates.